Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK/PD and Safety of Multiple Oral Doses of Dabigatran Etexilate in Healthy Japanese Males
NCT02171000Phase 1Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Apr 2005
- Primary completion
- May 2005
- Modality
- Small Molecules
01
Overview
Phase 1, open-label, single-arm trial of dabigatran in thromboembolism, sponsored by Boehringer Ingelheim. Primary endpoints: Change from baseline in physical examination, Change from baseline in vital signs and 3 more. Started Apr 2005; status: completed.
02
Drugs
dabigatran
03
Conditions
thromboembolism
Beyond the preview
Go deeper on NCT02171000.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02171000.